NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Start Multiple Choice Practice Test
Start Flash Cards

Practice this question and more.

For the reduction in risk of major CVD events in CAD/PAD with Rivaroxaban, what is the dosage?

  1. 20 mg QD

  2. 15 mg BID

  3. 10 mg QD

  4. 2.5 mg BID

The correct answer is: 2.5 mg BID

The other options are incorrect because they are either too high or too low of a dosage to be effective in reducing the risk of major CVD events in CAD/PAD with Rivaroxaban. Option A, 20 mg QD, is too high and could lead to adverse side effects, while option B, 15 mg BID, may also be too high and BID dosing can be challenging for patients to adhere to. Option C, 10 mg QD, may not be sufficient to effectively reduce the risk. Therefore, option D, 2.5 mg BID, is the recommended dosage for this purpose.

More Questions Like This